The forecasted import of insulin to Norway indicates a gradual decline from 2024 through 2028, starting at 7.52 thousand USD in 2024 and reaching 7.26 thousand USD by 2028. This represents a year-on-year decline with the rate of decrease varying slightly each year. In 2023, the import value was 7.59 thousand USD, indicating a 0.92% decrease from 2023 to 2024.
Key variations observed are:
- From 2024 to 2025: -0.93%
- From 2025 to 2026: -0.81%
- From 2026 to 2027: -0.95%
- From 2027 to 2028: -0.85%
The Compound Annual Growth Rate (CAGR) for the period from 2024 to 2028 is estimated at -0.88%.
Future trends to watch for include advancements in biotechnology that may influence insulin availability and pricing, changes in healthcare policies affecting drug imports, and potential improvements in insulin alternatives which could impact demand and import volumes.
